vs
Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and KAMADA LTD (KMDA). Click either name above to swap in a different company.
KAMADA LTD is the larger business by last-quarter revenue ($47.0M vs $30.1M, roughly 1.6× Dominari Holdings Inc.). KAMADA LTD runs the higher net margin — 11.3% vs -438.1%, a 449.4% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs 12.6%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs 12.0%).
Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.
DOMH vs KMDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.1M | $47.0M |
| Net Profit | $-131.8M | $5.3M |
| Gross Margin | — | 42.0% |
| Operating Margin | -8.9% | 16.6% |
| Net Margin | -438.1% | 11.3% |
| Revenue YoY | 220.4% | 12.6% |
| Net Profit YoY | -12426.2% | 37.1% |
| EPS (diluted) | $-6.94 | $0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.1M | — | ||
| Q3 25 | $50.8M | $47.0M | ||
| Q2 25 | $34.1M | $44.8M | ||
| Q1 25 | $8.1M | $44.0M | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $4.0M | $41.7M | ||
| Q2 24 | $6.2M | $42.5M | ||
| Q1 24 | $1.4M | $37.7M |
| Q4 25 | $-131.8M | — | ||
| Q3 25 | $125.2M | $5.3M | ||
| Q2 25 | $16.6M | $7.4M | ||
| Q1 25 | $-32.5M | $4.0M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $-4.2M | $3.9M | ||
| Q2 24 | $-6.1M | $4.4M | ||
| Q1 24 | $-5.4M | $2.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | 42.0% | ||
| Q2 25 | — | 42.3% | ||
| Q1 25 | — | 47.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 41.3% | ||
| Q2 24 | — | 44.6% | ||
| Q1 24 | — | 44.4% |
| Q4 25 | -8.9% | — | ||
| Q3 25 | -3.1% | 16.6% | ||
| Q2 25 | -57.0% | 15.8% | ||
| Q1 25 | -394.6% | 17.7% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | -79.1% | 12.7% | ||
| Q2 24 | -44.3% | 13.3% | ||
| Q1 24 | -205.2% | 10.7% |
| Q4 25 | -438.1% | — | ||
| Q3 25 | 246.4% | 11.3% | ||
| Q2 25 | 48.7% | 16.5% | ||
| Q1 25 | -400.5% | 9.0% | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | -104.2% | 9.3% | ||
| Q2 24 | -99.1% | 10.4% | ||
| Q1 24 | -398.0% | 6.3% |
| Q4 25 | $-6.94 | — | ||
| Q3 25 | $7.27 | $0.09 | ||
| Q2 25 | $1.12 | $0.13 | ||
| Q1 25 | $-3.02 | $0.07 | ||
| Q4 24 | $0.21 | — | ||
| Q3 24 | $-0.67 | $0.07 | ||
| Q2 24 | $-1.01 | $0.08 | ||
| Q1 24 | $-0.91 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.5M | $72.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $69.4M | $265.2M |
| Total Assets | $112.9M | $377.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | — | ||
| Q3 25 | $176.2M | $72.0M | ||
| Q2 25 | $28.2M | $66.0M | ||
| Q1 25 | $18.9M | $76.3M | ||
| Q4 24 | $8.2M | — | ||
| Q3 24 | $7.2M | $72.0M | ||
| Q2 24 | $12.1M | $56.5M | ||
| Q1 24 | $7.1M | $48.2M |
| Q4 25 | $69.4M | — | ||
| Q3 25 | $210.2M | $265.2M | ||
| Q2 25 | $88.6M | $260.0M | ||
| Q1 25 | $42.4M | $252.0M | ||
| Q4 24 | $39.9M | — | ||
| Q3 24 | $38.3M | $255.3M | ||
| Q2 24 | $42.4M | $251.2M | ||
| Q1 24 | $47.7M | $251.2M |
| Q4 25 | $112.9M | — | ||
| Q3 25 | $223.4M | $377.2M | ||
| Q2 25 | $109.3M | $368.2M | ||
| Q1 25 | $52.3M | $375.1M | ||
| Q4 24 | $47.1M | — | ||
| Q3 24 | $43.4M | $351.2M | ||
| Q2 24 | $49.1M | $351.0M | ||
| Q1 24 | $52.2M | $343.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.7M | $10.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 1.97× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.7M | — | ||
| Q3 25 | $-4.9M | $10.4M | ||
| Q2 25 | $-353.0K | $8.0M | ||
| Q1 25 | $1.2M | $-513.0K | ||
| Q4 24 | $-16.7M | — | ||
| Q3 24 | $-4.7M | $22.2M | ||
| Q2 24 | $1.4M | $14.0M | ||
| Q1 24 | $-8.6M | $1.0M |
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | 1.97× | ||
| Q2 25 | -0.02× | 1.09× | ||
| Q1 25 | — | -0.13× | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | 5.75× | ||
| Q2 24 | — | 3.15× | ||
| Q1 24 | — | 0.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
KMDA
Segment breakdown not available.
